Nandini Pharma Labs — limit review
CR-2026-04577·cases·Pharma·Pune — Baner
⏱SLA Breached · due 28 Jul 2026, 11:30
State
Reasoning
Owner
Deepa Nair
Exposure
₹44.50 cr
Risk tier
High
Documents
11
Open for
6d 3h
Evidence completeness70%Opened 24 Jul 2026=No contradictions
This case is indexed at portfolio level only
Nandini Pharma Labs Ltd · Reasoning. Its evidence graph, asserted values and derived metrics are held in the case store and load on open; that fetch is a backend call and is inert in this environment. The two fully modelled case files in this build are CR-2026-04417 and TF-2026-08815.
Open CR-2026-04417Case referenceCR-2026-04577
Content packP1
EntityNandini Pharma Labs Ltd